| abstract |
ThenThe present invention relates to the novel crystalline compoundsnA, which are in the form of their physiologically acceptable salts with acids, whereinnthe acidsnselectednare from group B consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, benzenesulfonic acid, p-toluenesulfonic acid, maleic acid, succinic acid, fumaric acid, D - (-) - tartaric acid, L - (+) - tartaric acid, naphthalene-2-sulfonic acid andnNaphthalene-1,5-disulfonicnas well as the polymorphs, the corresponding solvates and hydrates. |